M&A Deal Summary |
|
|---|---|
| Date | 2022-01-01 |
| Target | Patient Funding Alternatives |
| Sector | Healthcare Services |
| Buyer(s) | Leonard Green & Partners |
| Deal Type | Recapitalization |
SEARCH BY
| Category | Private Equity Firm |
|---|---|
| Founded | 1989 |
| PE ASSETS | 75.0B USD |
| Size | Mega |
| Type | Sector Agnostic |
Leonard Green & Partners is a mega-sized private equity firm that invests in established companies that are leaders in their respective markets. Leonard Green will consider investments in consumer and business services, consumer products, distribution, media, and retail. Typical transaction values for acquisitions are between $500 million and $2 billion, however, the firm is capable of closing transactions valued up to $5 billion. Types of transactions include public-to-private, recapitalizations of privately held businesses, growth capital, equity capital to facilitate acquisitions, turnarounds/restructurings, and acquisitions of divisions/assets from large corporations. Leonard Green & Partners was formed in 1989 and is based in Los Angeles, California.
| DEAL STATS | # |
|---|---|
| Overall | 96 of 107 |
| Sector: Healthcare Services M&A | 10 of 11 |
| Type: Recapitalization M&A Deals | 7 of 8 |
| State: Massachusetts M&A | 2 of 2 |
| Country: United States M&A | 91 of 99 |
| Year: 2022 M&A | 1 of 3 |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2021-12-16 |
Convergint
Schaumburg, Illinois, United States Convergint is a designer, installer, and services integrated building systems including electronic security, fire alarm, and life safety systems. Convergint was founded in 2001 and is based in Schaumburg, Illinois. |
Buy | - |
| DATE | TARGET | DEAL TYPE | VALUE |
|---|---|---|---|
| 2022-01-11 |
Pace
Minneapolis, Minnesota, United States Pace is a provider of analytical testing and related outsourced scientific solutions to the life sciences industry. Pace's Analytical Services division provides full-service testing, sampling, and analytical support services to detect trace-level organic and inorganic contaminants in air, water, wastewater, soil, biota, and waste. Pace's Life Sciences division provides a wide variety of testing services for the biopharmaceutical, pharmaceutical, medical device, and drug-device industries as well as early-stage drug development and manufacturing services with a broad range of pre-clinical and clinical capabilities for both small and large molecules. Pace was formed in 1978 and is based in Minneapolis, Minnesota. |
Buy | - |
